                         SEQUENCE LISTING

<110>  Oregon Health and Science University
       Tshala-Katumbay, Daniel Desire
 
<120>  PEPTIDE-BASED TREATMENT FOR NEURODEGENERATIVE DISEASES

<130>  899-83148-02

<150>  US 61/264,076
<151>  2009-11-24

<160>  18    

<170>  PatentIn version 3.5

<210>  1
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetanus toxin peptide

<400>  1

His Leu Asn Ile Leu Ser Thr Leu Trp Lys Tyr Arg 
1               5                   10          


<210>  2
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  misc_feature
<222>  (2)..(3)
<223>  Xaa can be any naturally occurring amino acid

<400>  2

Cys Xaa Xaa Cys 
1               


<210>  3
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  3

His Leu Asn Ile Leu Ser Thr Leu Trp Lys Tyr Arg Cys Gly His Cys 
1               5                   10                  15      


<210>  4
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic tetrapeptide


<220>
<221>  misc_feature
<222>  (2)..(3)
<223>  Xaa can be any naturally occurring amino acid

<400>  4

Lys Xaa Xaa Lys 
1               


<210>  5
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide with four lysines

<400>  5

Lys Lys Lys Lys 
1               


<210>  6
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  6

His Leu Asn Ile Leu Ser Thr Leu Trp Lys Tyr Arg Lys Lys Lys Lys 
1               5                   10                  15      


<210>  7
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide sequence

<400>  7

Thr Ala Cys Ala Thr Ala Gly Ala Gly Ala Ala Thr Gly Gly Cys Cys 
1               5                   10                  15      


Ala Gly Thr Cys Thr Thr Thr Thr Gly Ala Cys 
            20                  25          


<210>  8
<211>  26
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide sequence

<400>  8
gcacaactgg gtaaggttcc tattcc                                            26


<210>  9
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide sequence

<400>  9
gatctgaaag ccaatgagtc tcggc                                             25


<210>  10
<211>  26
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide sequence

<400>  10
gcacaactgg gtaaggttcc tattcc                                            26


<210>  11
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide sequence

<400>  11
cctccctgga gaagagcta                                                    19


<210>  12
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide sequence

<400>  12
actcctgctt gctgatccac                                                   20


<210>  13
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide sequence

<400>  13
gcaaaactga aggcagaagg                                                   20


<210>  14
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  14
gagtccacca aggactctgc                                                   20


<210>  15
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  15
agtggtggcc actaatggag                                                   20


<210>  16
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  16
cttcaaattt ggcccgagta                                                   20


<210>  17
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  oligonucleotide synthetic primer

<400>  17
cggaacctga ggagagag                                                     18


<210>  18
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  18
ataggtgccc ccaatttcat                                                   20


